General
Preferred name
tetracosactide
Synonyms
Tetracosactrin ()
Alpha 1-24 corticotropin/ COSYNTROPIN ()
COSYNTROPIN ()
[125I]ACTH-(1-24) ()
Synacthen Depot ()
Tetracosactide hexaacetate ()
Cosyntropin hexaacetate ()
Cortrosyn ()
Synacthen ()
Vicotrope ()
Tetracosactide Acetate ()
Corticotropin Tetracosapeptide ()
Tetracosactide ()
Cosyntropin acetate ()
Tetracosactide hexacetate ()
Cosyntropin (acetate) ()
P&D ID
PD071760
CAS
16960-16-0
60189-34-6
Tags
available
drug
Approved by
FDA
First approval
1970
Drug Status
approved
Max Phase
Phase 4
Drug indication
Hormone (adrenocorticotropic)
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Synthetic fragment of ACTH. The sequence is the same in the human and rodent peptides
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
33
Molecular Weight
2931.58
Hydrogen Bond Acceptors
39
Hydrogen Bond Donors
42
Rotatable Bonds
93
Ring Count
9
Aromatic Ring Count
6
cLogP
-7.96
TPSA
1158.72
Fraction CSP3
0.58
Chiral centers
22.0
Largest ring
6.0
QED
0.01
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
